MedTrace Logo

Paraurethral Transplantation of Autologous Muscle Derived Stem Cells for Treatment of Stress Incontinency

NCT02156934 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-12-04

No results posted yet for this study

Summary

This study was designed to provide confirmation of efficacy of muscle derived stem cells (MDCs) for the treatment of SUI in women.

Conditions

  • Stress Urine Incontinency

Interventions

BIOLOGICAL

paraurethral injection

Paraurethral injection of muscle derived stem cell in patients with stress urine incontinency.

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid Gourabi, PhD · Head of Royan Institute

  • Nasser Aghdami, MD,PhD · Head of Department of Regenerative Medicine & Cell therapy center of Royan Institute

  • Farzaneh Sharifiaghdas, MD · Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences

  • Farshad Zohrabi, MD · Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences

  • Reza Moghadasali, PhD · Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02156934 on ClinicalTrials.gov